Microbicides Research, Development, and Introduction
ID: 187913Type: Posted
Overview

Buyer

Agency for International Development (USAID)

Award Range

$100K - $2M

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/187913
Timeline
    Description

    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovation in microbicide technologies to reduce HIV infection rates among women and girls. The initiative seeks to support activities that align with the Global Health Initiative (GHI) principles, focusing on a woman- and girl-centered approach, enhancing health system capabilities, and ensuring gender considerations are integrated into program design and implementation. This funding opportunity, with an award ceiling of $2,250,000 and a floor of $100,000, is open to various eligible applicants, and interested parties can reach out to Kathleen Bumpass at kbumpass@usaid.gov or by phone at 202-567-5008 for further information. The closing date for applications is to be determined.

    Point(s) of Contact
    kbumpass@usaid.gov
    Files
    Title
    Posted
    microbicide rd q&a final 080912.docx
    microbicide.bin
    Similar Opportunities
    Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is seeking expert input through a Request for Information (RFI) aimed at accelerating HIV vaccine research and development in low- and middle-income countries (LMICs). This initiative is designed to gather recommendations on opportunities, challenges, and gaps in HIV vaccine R&D, particularly focusing on collaborative ecosystems, efficient manufacturing, and community engagement. The RFI underscores USAID's commitment to enhancing partnerships and locally-led development in regions significantly impacted by HIV, including outreach to historically black colleges and universities (HBCUs) and minority-serving institutions (MSIs). Interested parties must submit their responses electronically by May 24, 2024, at 5:00 PM EDT, adhering to specific formatting guidelines, and can direct inquiries to Simone Cho at scho@usaid.gov.
    Comprehensive District-Based Support for Better HIV/TB Patient Outcomes
    Active
    South Africa USAID-Pretoria
    The United States Agency for International Development (USAID) Mission to Southern Africa is seeking applications for a five-year cooperative agreement aimed at implementing comprehensive district-based HIV-related services to improve patient outcomes. This initiative is part of a broader effort to enhance health services in the region, specifically targeting better management and support for HIV and tuberculosis patients. With an estimated total program funding of $75 million, the agency anticipates awarding four grants, with individual awards ranging from $1 to $20 million. Interested organizations are encouraged to participate in a pre-application conference scheduled for May 14, 2012, in Johannesburg, South Africa, to clarify the application process and technical objectives; registration is required by January 23, 2012. For further inquiries, applicants can contact Beatrice Lumande at Applications4@usaid.gov or by phone at +27 12 452 2377.
    HIV/AIDS Activities
    Active
    Burundi USAID-Bujumbura
    The United States Agency for International Development (USAID) in Burundi is seeking innovative ideas and strategies to enhance its HIV/AIDS programming through a Request for Information (RFI) issued on March 17, 2022. The primary objective of this RFI is to gather insights on addressing gaps and challenges in the HIV response in Burundi, particularly focusing on clinical programming, community involvement, treatment interruptions, and the needs of orphans and vulnerable children. This initiative is crucial for improving the effectiveness and equity of HIV services in alignment with global health initiatives, emphasizing the importance of community participation in achieving epidemic control. Interested parties can submit their responses electronically by March 31, 2022, to Liliane Gatunange at lgatunange@usaid.gov, with no individual feedback provided to respondents.
    HIV Prevention Among Adolescent Girls and Young Women and Other Vulnerable Youth Populations - DREAMS North
    Active
    South Africa USAID-Pretoria
    The South Africa USAID-Pretoria is offering a federal grant opportunity titled "HIV Prevention Among Adolescent Girls and Young Women and Other Vulnerable Youth Populations - DREAMS North." This initiative aims to significantly reduce HIV incidence among adolescent girls and young women (AGYW) aged 10-24 in high-prevalence areas of South Africa, specifically targeting the provinces of Mpumalanga, Gauteng, and Limpopo. The program focuses on enhancing access to comprehensive, evidence-based prevention interventions while addressing the socio-economic determinants of HIV risk, including gender-based violence and health service utilization. Eligible local entities are invited to submit concept papers by February 11, 2025, with an anticipated funding range of $52 million to $58 million over five years, and a 10% cost-sharing requirement is mandated for applicants. For further inquiries, interested parties can contact Alejandra Garcia at pretoriaapplications@usaid.gov.
    New Partners Initiative Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is inviting applications for the New Partners Initiative Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE), aimed at accelerating the development of a safe and effective HIV vaccine through collaborative research led by African scientists and institutions. This funding opportunity includes at least two cooperative agreements, with a total funding ceiling of $98.5 million over five years, structured around two main objectives: enhancing African-led clinical research and advancing promising immunogens towards first-in-human studies. The program emphasizes innovative, locally-led approaches and is open to a wide range of eligible applicants, including nonprofits without 501(c)(3) status, with a focus on projects predominantly within African countries to leverage local capabilities in addressing global HIV vaccine research challenges. Interested parties must submit a concept paper by January 28, 2025, and can contact Elton Fortson at npithrive@usaid.gov for further information regarding the application process.
    The USAID Global Health Development Innovation Accelerator Broad Agency Announcement
    Active
    Agency for International Development
    The Agency for International Development (USAID) is inviting organizations to participate in the Global Health Development Innovation Accelerator Broad Agency Announcement (BAA), aimed at co-creating and scaling innovative solutions to address critical global health challenges. This initiative encourages a diverse range of eligible applicants, including public and private organizations, non-profits, and institutions of higher education, to submit proposals that demonstrate strong potential impacts on reducing maternal and neonatal mortality, particularly in low- and middle-income countries. The program emphasizes flexibility in partnerships and allows for multiple submissions from applicants, with funding amounts ranging from $250,000 to $2 million, and the application process is strictly time-bound with no extensions available. Interested parties should refer to individual addenda for specific contact information and submission deadlines, as the response dates are established by those addenda.
    HIV/AIDS Orphans and Vulnerable Children and Adolescent Girls and Young Women Follow On Activity
    Active
    South Sudan (USAID)-Juba
    USAID South Sudan is forecasting a federal grant opportunity titled "HIV/AIDS Orphans and Vulnerable Children and Adolescent Girls and Young Women Follow On Activity," aimed at enhancing the resilience of high-risk children, youth, and their caregivers in South Sudan. The program's objectives include preventing new HIV infections, improving care retention and treatment adherence for those living with HIV, and reducing violence against vulnerable populations, particularly adolescent girls and young women. This initiative is critical for addressing health disparities and improving the overall well-being of affected communities in high-burden areas. Interested applicants must submit their proposals electronically by August 1, 2022, with an estimated award date of October 1, 2022. For further inquiries, contact Michael P. Loro at mloro@usaid.gov or by phone at 202-216-6279.
    Systems Strengthening for Better HIV/TB Patient Outcomes
    Active
    South Africa USAID-Pretoria
    The South Africa USAID-Pretoria is offering a federal grant opportunity titled "Systems Strengthening for Better HIV/TB Patient Outcomes," aimed at enhancing South African Government systems to improve patient outcomes and prevent HIV through comprehensive clinic-based services. Eligible applicants include local South African non-governmental organizations (NGOs) and for-profit organizations that meet specific criteria, with a focus on addressing all three objectives outlined in the Request for Application (RFA) for optimal evaluation. The program has an estimated total funding of $425 million, with individual awards ranging from $10 million to $150 million, and is expected to result in approximately eight awards. Interested organizations should submit their concept papers and full applications as per the guidelines provided, with inquiries directed to Beatrice Lumande at Applications4@usaid.gov or by phone at +27 12 452 2377.
    The USAID Global Health Broad Agency Announcement for Research and Development (2018)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) has issued the Global Health Broad Agency Announcement (BAA) for Research and Development, aimed at fostering innovative solutions to critical global health challenges in developing countries. This BAA invites organizations to collaborate with USAID in co-creating research concepts that address significant health issues, such as maternal and child mortality and the prevention of infectious diseases, without directly soliciting funding proposals. The initiative emphasizes partnerships and cooperative engagements, focusing on the capability of participants to contribute to USAID's health objectives, with evaluations based on potential impact at scale. Interested parties can inquire further by contacting USAID at GH-BAA-2018@usaid.gov, with the BAA remaining open until May 30, 2022, for future Addenda that will provide specific funding information.
    Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases
    Active
    Agency for International Development
    The Agency for International Development (USAID) is offering a federal grant titled "Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases" aimed at enhancing the preparedness and response capabilities of non-governmental organizations (NGOs) in the face of infectious disease outbreaks. The program seeks to establish standby capacity by improving technical coordination and multi-sectoral responses, particularly in health, nutrition, water, sanitation, and agriculture, to effectively manage humanitarian emergencies. With a total funding ceiling of $8 million for a single award, applicants are required to submit concept notes by April 27, 2018, and can direct inquiries to 720FDA18APS00001@ofda.gov for further clarification on the application process.